PDS Biotechnology Corporation logo

PDS Biotechnology Corporation (PDSB) Q2 2024 Earnings

PDSB·Reported August 13, 2024·Before market open

Diluted EPS came in at $-0.23, beat the $-0.31 consensus by $0.08.

Diluted EPS
$-0.23beat by $0.08
Consensus: $-0.31
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about PDS Biotechnology Corporation's Q2 2024 earnings report.

PDS Biotechnology Corporation (PDSB) reported Q2 2024 earnings on August 13, 2024 before market open.

PDS Biotechnology Corporation reported diluted EPS of $-0.23 for Q2 2024.

EPS beat the consensus estimate of $-0.31 by $0.08.

You can read the 10-Q periodic report (0001140361-24-037067) directly on SEC EDGAR. The filing index links above go to sec.gov.